Mechanism of Action: Xanthine Oxidase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Xanthine Oxidase Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell | ALLOPURINOL | allopurinol | TABLET;ORAL | 077353-002 | Sep 8, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Indoco | ALLOPURINOL | allopurinol | TABLET;ORAL | 204467-001 | Jul 28, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Indoco | ALLOPURINOL | allopurinol | TABLET;ORAL | 204467-002 | Jul 28, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | ALLOPURINOL | allopurinol | TABLET;ORAL | 018832-002 | Sep 28, 1984 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Accord Hlthcare | ALLOPURINOL | allopurinol | TABLET;ORAL | 203154-001 | May 6, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm Industries | ALLOPURINOL | allopurinol | TABLET;ORAL | 071450-002 | Jan 9, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Harman Finochem | ALLOPURINOL | allopurinol | TABLET;ORAL | 214443-001 | Mar 7, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
